Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod

Original language	English
Journal	Neurology® neuroimmunology & neuroinflammation
Volume	9
Issue number	4
DOIs	https://doi.org/10.1212/NXI.0000000000001178
Publication status	Published - 1 Jul 2022

ID: 23943906

Generic Portal